Newsletter summary

[Mindray Medical: revenue growth will accelerate in the second half of the year] Securities Times e Company NewsPokerstreepMindray Medical said at the performance presentation meeting that from the perspective of the external environment, the rectification activities of the domestic medical industry have gradually become normal since 2024, and the medical equipment renewal project is expected to open in the second half of the year.Pokerstreep...

Text of news flash

[Mindray Medical: income growth will accelerate in the second half of the year] according to the Securities Times e Company, Mindray Medical said at the performance presentation meeting that from the external environment, the rectification activities of the domestic medical industry have gradually become normal since 2024, and the medical equipment renewal project is expected to contribute in the second half of the year, while there is still a lot of room for improvement in the international market. Internally, there are opportunities for the release of blockbuster products in all production lines this year, such as minimally invasive surgical consumables businesses such as ultrasonic scalpel and endoscopic stapler; chemiluminescence is expected to add about 20 new core projects will make a significant contribution to reagent output; the new installed capacity of the fully self-developed TLA assembly line MT-8000 is expected to exceed the historical stock. Ultra-high-end ultrasound ResonaA20 will accelerate the breakthrough of ultrasound business in high-end hospitals around the world at the same time. Therefore, on the whole, the company is full of confidence in achieving the set growth target for the whole year, and the revenue growth rate will accelerate in the second half of the year.